Resultados de procura - David Kavanagh

Limitar resultados
  1. 1
    Genetics and complement in atypical HUS

    Genetics and complement in atypical HUS por David Kavanagh, Tim Goodship

    Publicado 2010
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

    Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome por Edwin Wong, David Kavanagh

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea

    Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea por Vicky Brocklebank, David Kavanagh

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Diseases of complement dysregulation—an overview

    Diseases of complement dysregulation—an overview por Edwin Wong, David Kavanagh

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Diagnosis and treatment of thrombotic microangiopathy

    Diagnosis and treatment of thrombotic microangiopathy por Gemma L. Thompson, David Kavanagh

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Complement therapy in atypical haemolytic uraemic syndrome (aHUS)

    Complement therapy in atypical haemolytic uraemic syndrome (aHUS) por Edwin Wong, Tim Goodship, David Kavanagh

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Atypical haemolytic uraemic syndrome

    Atypical haemolytic uraemic syndrome por David Kavanagh, Tim Goodship, Anna Richards

    Publicado 2006
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Atypical Hemolytic Uremic Syndrome, Genetic Basis, and Clinical Manifestations

    Atypical Hemolytic Uremic Syndrome, Genetic Basis, and Clinical Manifestations por David Kavanagh, Timothy H.J. Goodship

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Atypical Hemolytic Uremic Syndrome

    Atypical Hemolytic Uremic Syndrome por David Kavanagh, Tim Goodship, Anna Richards

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Peritoneal dialysis-associated peritonitis in Scotland (1999-2002)

    Peritoneal dialysis-associated peritonitis in Scotland (1999-2002) por David Kavanagh, Gordon Prescott, Robert Mactier

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Thrombotic Microangiopathy and the Kidney

    Thrombotic Microangiopathy and the Kidney por Vicky Brocklebank, Katrina Wood, David Kavanagh

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Complement and the prothrombotic state

    Complement and the prothrombotic state por Christoph Q. Schmidt, Hubert Schrezenmeier, David Kavanagh

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Transplantation in Atypical Hemolytic Uremic Syndrome

    Transplantation in Atypical Hemolytic Uremic Syndrome por David Kavanagh, Anna Richards, Tim Goodship, Hannu Jalanko

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    A national specialized service in England for atypical haemolytic uraemic syndrome—the first year’s experience

    A national specialized service in England for atypical haemolytic uraemic syndrome—the first year’s experience por Neil Sheerin, David Kavanagh, Timothy H.J. Goodship, Sally Johnson

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic

    Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic por Thomas M Hallam, Stephen J. Sharp, Aikaterini Andreadi, David Kavanagh

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Developments in anti-complement therapy; from disease to clinical trial

    Developments in anti-complement therapy; from disease to clinical trial por Claire L. Harris, Richard B. Pouw, David Kavanagh, Ruyue Sun, Daniel Ricklin

    Publicado 2018
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Advances in understanding of pathogenesis of aHUS and HELLP

    Advances in understanding of pathogenesis of aHUS and HELLP por Celia J. Fang, Anna Richards, M. Kathryn Liszewski, David Kavanagh, John P. Atkinson

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities

    Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities por Isabell Pechtl, David Kavanagh, Nicola McIntosh, Claire L. Harris, Paul N. Barlow

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Structural basis for sialic acid–mediated self-recognition by complement factor H

    Structural basis for sialic acid–mediated self-recognition by complement factor H por Bärbel S. Blaum, Jonathan P. Hannan, Andrew P. Herbert, David Kavanagh, Dušan Uhrı́n, Thilo Stehle

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Factor B as a therapeutic target for the treatment of complement-mediated diseases

    Factor B as a therapeutic target for the treatment of complement-mediated diseases por David Kavanagh, Jonathan Barratt, Anna Schubart, Nicholas J.A. Webb, Matthias Meier, Fádi Fakhouri

    Publicado 2025
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: